Radiation-induced Fibrosis
Radiation-induced Fibrosis - Related Videos
09:27
The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
0 Views •
Cited by 11 •
2016
We describe a method to produce an animal model of liver fibrosis in the rat, and assess the degree of fibrosis by histological examination of the liver. The model can be used to study the development of liver disease as well as to test the efficacy of potential anti-fibrotic agents.
06:21
Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
0 Views •
Cited by 13 •
2016
We present a diffuse optical spectroscopic (DOS) approach that provides quantitative optical biomarkers of skin response to radiation. We describe DOS instrumentation design, optical parameters extraction algorithms and the animal handling procedures required to yield representative data from a pre-clinical mouse model of radiation induced erythema.
02:59
Biological Effects of Radiation
0 Views •
2020
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
0 Views •
Cited by 9 •
2015
Stereotactic ablative body radiation therapy (SBRT) involves the precise delivery of high-dose radiation to cancer tumor targets. A novel SBRT platform offers a first-of-its-kind gimbaled radiation accelerator mounted within a pivoting O-ring gantry capable of dynamic image-guided tumor tracking. Here, we describe dynamic tumor tracking for lung targets.
07:04
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
0 Views •
Cited by 121 •
2017
This protocol describes an assay for measuring CFTR function and CFTR modulator responses in cultured tissue from subjects with cystic fibrosis (CF). Biopsy-derived intestinal organoids swell in a cAMP-driven fashion, a response that is defective (or strongly reduced) in CF organoids and can be restored by exposure to CFTR modulators.
FAQs
Persistent inflammation and radiation-related tissue injury can maintain signals that activate fibroblasts. These cells then produce excessive extracellular matrix proteins, including collagen. As matrix material accumulates, the affected tissue becomes progressively less elastic and more rigid. This sequence connects an initial treatment-related injury with delayed structural changes that may impair the function of irradiated organs.
Collagen is a major component of the extracellular matrix, the structural network surrounding cells. When fibroblasts produce it excessively, the matrix accumulates rather than being restored to a balanced state. The resulting tissue stiffening and loss of elasticity can reduce normal organ function, making collagen-associated changes important markers of treatment-related injury in cancer research.
Because the process can develop progressively after the original radiation exposure, later tissue changes may reflect treatment-related injury rather than an immediate treatment response. This timing creates an interpretive challenge in cancer care and research. Understanding the delayed course helps investigators examine long-term complications and work toward distinguishing fibrosis from recurrent disease.
Biomarker studies can help identify biological signals associated with treatment-related tissue injury and the later development of fibrosis. In cancer research, these markers may support risk prediction and provide information that is not apparent from treatment history alone. Their development could also help distinguish radiation-induced changes from recurrent disease during follow-up.
Investigating why normal tissues develop fibrosis can inform strategies for predicting which patients face greater risk of long-term complications. These insights may support radiation dose optimization, with the goal of limiting injury to normal tissue while retaining the intended cancer-treatment benefit. The same research can identify opportunities for earlier recognition and intervention after treatment.
A central goal is to limit persistent inflammation, fibroblast activation, and excessive extracellular matrix accumulation before structural damage becomes more disabling. Research findings can guide the development of therapies intended to reduce long-term treatment complications. They also support early-intervention strategies and help clarify how radiotherapy affects normal tissues alongside its role in cancer treatment.